Piramal Pharma Limited Right Issue

₹1,050.00 Cr BSE, NSE 8 Aug 2023 – 17 Aug 2023

Closed Ratio: 5 : 46 BSE, NSE
HomeRight Issue › Piramal Pharma Limited
← Back to List
Issue Price
₹81.00
Face Value
₹10.00
Issue Size (Shares)
129,629,630
Issue Size (₹ Cr.)
₹1,050.00
📅 Right Issue Timetable
Last Date to Buy SharesTue, Aug 1, 2023
Record DateWed, Aug 2, 2023
Credit of Rights Entitlements
Bid/Offer Opens OnTue, Aug 8, 2023
Issue Open DateTue, Aug 8, 2023
Renunciation Last DateThu, Aug 10, 2023
Bid/Offer Closes OnThu, Aug 17, 2023
Issue Close DateThu, Aug 17, 2023
Deemed Date of AllotmentWed, Aug 23, 2023
Credit DateThu, Aug 24, 2023
Listing DateMon, Aug 28, 2023
📋 Right Issue Details
Issue Size (Shares)129,629,630
Issue Size (Amount)₹1,050.00 Cr.
Issue Price₹81.00 per share
Face Value₹10.00 per share
Entitlement Ratio5 : 46
Listing AtBSE, NSE
Terms of Payment₹81 per share payable in full at the time of application.
📊 Company Financials (Restated)
Period Ended2023-03-312022-03-312021-03-31
Income7,306.666,834.906,479.01
EBITDA
Net Worth5,968.456,069.945,076.75
Reserves & Surplus5,181.795,290.694,488.62

Amount in ₹ Crore

🏢 About the Company
Incorporated in 2020, Piramal Pharma Limited a flagship company of Piramal Group offers pharmaceutical products and services across a domestic and global distribution network.

The company has 15 global manufacturing facilities and a global distribution network in over 100 countries.

Piramal Pharma includes:

Piramal Pharma Solutions (PPS), is an integrated Contract Development and Manufacturing Organization (CDMO). It develops and manufactures solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies.
Piramal Critical Care (PCC), is a Complex Hospital Generics business whose product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anesthetics, injectable anti-infectives, and other therapies.
India Consumer Healthcare (ICH) business, selling over-the-counter products.
📞 Company Contact
CompanyPiramal Pharma Limited
AddressGround Floor, Piramal Ananta,
Agastya Corporate Park, Kamani Junction,
LBS Marg, Kurla, Mumbai 400 070
Mumbai, Maharashtra, 400070
Phone+91 22 3802 3000
Emailshareholders.ppl@piramal.com
WebsiteVisit ↗
📝 Registrar
NameMUFG Intime India Pvt.Ltd
Phone022-49186000
Emailppl.rights@linkintime.co.in
WebsiteVisit ↗